All Search Results
-
Gynecologic Oncology
Learn more about the comprehensive care and state-of-the-art treatment options available through the Orlando Health Cancer Institute partnership.
-
Comprehensive Care for Joint Replacement (CJR)
Selection Criteria for Collaborators
-
Compliance and Ethics
The Corporate Compliance Program aids in detecting and preventing deviations from expected behavior, whether intentional or not.
-
Compliance and Ethics
The Compliance and Ethics Program aids in detecting and preventing deviations from expected behavior, whether intentional or not.
-
Patients & Visitors
Information and resources for patients, parents and visitors of Arnold Palmer Hospital for Children.
-
Infections Related To Compromised Immunity
A compromised immune system means that your body does not have the ability to defend against illness or medical challenges. If you have heart disease, diabetes, cancer or any chronic illness, or if you have an acute illness that seems to last for a long period of time, your immune system may be considered compromised.
-
Comprehensive Multiple Sclerosis Services
Multiple sclerosis (MS) touches every area of your life, from your physical and emotional wellbeing to your ability to complete everyday tasks. That’s why our team provides the support and services you need to address the unique challenges that come with an MS diagnosis and help you live your best possible life. We offer a wide range of services, including:
-
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult (AYA) Survivors of Hodgkin and Non-Hodgkin Lymphoma
-
Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
-
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
A Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
